MULTIPLE MYLOMA

Clinical trials for MULTIPLE MYLOMA explained in plain language.

Never miss a new study

Get alerted when new MULTIPLE MYLOMA trials appear

Sign up with your email to follow new studies for MULTIPLE MYLOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take aim at multiple myeloma from the start

Disease control Recruiting now

This early study tests a new treatment called RN1201 for people newly diagnosed with multiple myeloma, a type of blood cancer. RN1201 uses specially engineered immune cells from a healthy donor to target and kill cancer cells. Participants receive a single infusion of these cells…

Matched conditions: MULTIPLE MYLOMA

Phase: PHASE1 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

MULTIPLE MYLOMA

Get alerted when new MULTIPLE MYLOMA trials appear

Engineered immune cells take aim at multiple myeloma from the start